Diamond Medino Capital

Diamond Medino Capital is a specialized venture capital firm that advances healthcare technologies through its ecosystem. It identifies promising early-stage medical device and drug discovery startups, providing comprehensive support from development through regulatory approval and market entry. The firm integrates medical understanding with engineering expertise, leveraging expert teams to accelerate research into solutions.

Founded in 2022, the firm was established by a team including Nobuyoshi Ehara, a seasoned investor who founded Unison Capital, Inc. in 1999 and pioneered private equity in Japan. Their insight: understanding medical needs and fostering cross-sector collaboration are crucial for swiftly deploying impactful innovations and achieving societal transformation.

Diamond Medino Capital primarily serves medical researchers and early-stage healthcare startups seeking capital and operational expertise. Its long-term vision: transform global health by cultivating medical research talents, ensuring successful technologies rapidly return to society through timely investment and partnerships, creating a healthier world.